top of page

Search Results

Search results for "Can Cao"

Results found for "Can Cao"

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    Welcome back GPCR fans, The pace of GPCR innovation is accelerating at a rate that can be difficult to Learn how his research aims to develop models that can distinguish between active and inactive ligands gap between disciplines:  Get practical advice from a computational expert on how wet-lab scientists can The right information at the right time can mean the difference between a breakthrough and a dead end GPCR Premium Membership gives you direct access to the experts and insights that can redefine your work

  • đŸ€ŻMind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⊿ Nov 18 - 24, 2024

    ,  Yongfeng Liu ,  Marion Lanier ,   Brian K Shoichet ,  Esther Martinborough ,  Jonathan F Fay ,  Can Cao ,   Bryan L Roth , et al. GPCR Events You can begin organizing and marking a few dates in 2025 .

  • Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms

    Multiple 14-3-3 isoforms exist, and a GPCR can differentially interact with different 14-3-3 isoforms We found that some agonist-induced GPCR/14-3-3 signal intensities can rapidly decrease. Furthermore, we found that certain GPCR ligands can regulate GPCR/14-3-3 signals temporally, suggesting

  • 📰 GPCR Weekly News, April 8 to 14, 2024

    their investigation on Molecular insights into G protein coupling specificity at a class A GPCR Jianjun Cao If you have any research you would like to showcase to our community, you can submit a poster presentation

  • Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⊿ Nov 24 - Dec 1, 2024

    facilitates cryo-EM structure determination of a Family A GPCR Jun Xu , Geng Chen , Haoqing Wang , Sheng Cao Starting in 2025, only Premium Members can access Classified GPCR News.

  • Four Reasons to Measure GPCR Signaling Bias in Drug Discovery

    pleiotropically coupled to multiple intracellular pathways, and different ligands at the same receptor can measurements improve candidate selection at every stage of the discovery pipeline How biased ligands can Bias measurements can identify structurally differentiated hits from high-throughput screens. Without multi-pathway assays, selectivity assessments can be misleading. A biased ligand can be designed to favor pathways.

  • Understanding Orthosteric Binding: The Key to Drug Action

    The Importance of Binding in Drug Action In pharmacology, binding must happen before any drug effect can When a drug binds to its target, it initiates a series of events that can lead to a physiological response This knowledge can guide modifications to improve binding affinity and bioavailability. This understanding can enhance your appreciation for drug development and therapeutic action. By embracing these concepts, we can pave the way for more effective treatments in the future.

  • Beyond Clearance: The Strategic Power of Irreversible Drug Binding

    But it’s also the reason a promising lead can turn toxic overnight. This session unpacks how persistent binding can either accelerate your program—or quietly kill it. Such interactions can disrupt metabolic detoxification and lead to delayed, systemic toxicity. Getting this wrong doesn’t just slow a program—it can mislead the entire development strategy . Irreversible binding can turn enzyme interactions into make-or-break kinetic events.

  • Choosing the Right GPCR Calcium Assay Readout for Measuring Receptor Activation

    intracellular calcium concentrations rise, these dyes generate measurable fluorescent signals that can This approach minimizes variability associated with dye loading and can improve quantitative consistency GPCR Calcium Assay Cell Models from Eurofins DiscoverXÂź Selecting the right cell model can be just as Calcium assays are also nondestructive and can be performed in living cells, allowing researchers to In addition, assay performance can be highly sensitive to variations in cell density and dye loading,

  • Advantages of Fluorescent Probes in GPCR Assays

    They can also further pharmacological and structural studies, as they can be used to determine receptor It can be appreciated how fast the ligand diffuses and is distributed homogeneously within monolayers This can lower the quality of long-term imaging studies but can be fixed by using stable fluorescent This can be fixed by using fluorescent dyes that emit at longer wavelengths, where fluorescence from Confocal microscopy is a technique that can be used to mitigate this issue.

  • Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery

    For GPCR drug discovery, those hidden details can determine whether a compound advances or stalls. By modulating receptor expression or sensitivity, we can shift the “lens” through which drug activity These aren’t abstract academic puzzles—they’re decision points that can make or break a program. Monthly AMAs  where you can challenge Terry with your toughest questions. Decades of insight distilled  into frameworks you can apply immediately.

  • Understanding Biased Signaling in GPCRs

    These systems are used here as resolved examples of how interface binding can stabilize specific signaling Key implications: SBI-553 illustrates how arrestin signaling can be stabilized through direct receptor–Gαo PCO371 shows that G protein bias can be achieved through intracellular binding that suppresses arrestin This limitation affects how signaling data can be interpreted when receptor behavior depends on cell Allosteric modulators can alter signaling efficacy without changing ligand affinity, uncoupling binding

  • The GPCR antibody signal that should have been there

    You can keep validating forever. But you can characterize an antibody: under these conditions, it does this. And within a receptor family the sequences run so close, two chemokine receptors can share more than Ball put it, you can be “doomed before you even shoot a rabbit.” medicine, then a turn to the research bench, and learned only there how unforgiving these reagents can

  • Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids

    assays—particularly membrane-based radioligand binding—often provide high-throughput measurements, yet they can , where nuanced shifts in receptor conformation affect signaling outcomes, a whole-cell environment can This dataset highlights how HCS can be used both to triage compound series and to extract quantitative and in concentration–response formats  Why image-based confirmation (and transparent Ki reporting) can Using HEK-293 cells stably expressing CB2R, fluorescent tracers such as CELT-331 can report on ligand

  • Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success

    difference between orthosteric vs. allosteric mechanisms isn’t just academic — an orthosteric antagonist can That can be powerful but blunt. This means they can be more selective, avoid pathway saturation, and preserve physiological nuance. Unlike orthosterics, they can discriminate between agonists, pathways, and even durations of action. Translational Relevance: From Bench to Clinic Misjudging orthosteric vs allosteric behavior can derail

  • Radioligands vs. Fluorescent Ligands: Binding Assays

    They are ligands labeled with radioactive isotopes which can be used in binding assays to quantify other Besides binding assays, they can also be used to study receptor density, binding sites and ligand kinetics This can be done with agonists, antagonists, reverse agonists in the case of GPCRs. Figure 1. Fluorescent ligands can be used at a broader range of concentration without losing accuracy, as well Live-cell imaging:  Fluorescent ligands can be used to study cellular and tissue location of a receptor

  • GPCR Collaboration: From Models to Medicine

    His group is trained to explain exactly what a model can predict and where its limits are. If docking can suggest binding modes but can’t resolve nanomolar potency differences, they say so. No single discipline can cover all the ground . Modelers can generate binding hypotheses, but they remain untested until validated experimentally. He resists hype, focusing instead on predictions collaborators can actually use.

  • When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA

    What initially appears mechanistically clear can become more nuanced when additional experiments are Functional assays can suggest clarity while quietly masking complexity, creating the illusion of competitive It can redirect chemistry strategy, distort translational assumptions, and conceal liabilities that emerge — A Distinctive Allosteric Readout Allosteric systems exhibit probe dependence: the same modulator can High-expression systems maximize detection sensitivity and can reveal subtle efficacies.

  • Why GPCR Biologic Drugs Stabilize Active States Small Molecules Struggle to Reach

    It selects for it, through the geometry of where its contacts can reach. The small molecule can show affinity for the site. It can produce binding. conformational outcome accessible from it depends on how much of the binding architecture a ligand can The active state can be stabilized through a different geometric route, one that does not require the good binding and weak activation, repeatedly, may be encountering the limit of what a small molecule can

  • Understanding the Journey: Catherine Demery's Path to Addiction Science

    Industry can build skills that academia often overlooks. Passion can lead to groundbreaking discoveries and a fulfilling career. However, embracing uncertainty can lead to unexpected opportunities. In life and career, taking risks can lead to personal and professional growth. This mindset can lead to a more fulfilling and successful career.

  • Conjugation Strategies for Probe Development

    You can check what we do here on our website!   This conjugation is very useful for tagging biomolecules and can also be used to develop fluorescent Thanks to the unique linker structure we obtain, which can be divided into three differentiated parts , we can modify the rigidity of the linker as well as the physicochemical properties of the whole probe This property comes from the wide chemical space this reaction can access – we can substitute one reagent

  • How Fast Does a Drug Work?

    Two compounds can show identical affinities on paper, but their biological outcomes can differ dramatically Every day spent misunderstanding what your assays are truly showing you can lead to costly missteps—wasted is essential for pipeline efficiency: How fast a ligand binds (k₁) and how long it stays bound (k₂)  can conditions —such as the presence of endogenous ligands— change kinetic behavior , and ignoring this can equilibrium Interpret competition experiments with confidence Recognize how kinetic rate constants can

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    Even the most elegant GPCR ligand can fail if it never reaches its receptor. They can metabolize, inactivate, or transform your compound, sometimes into a toxic byproduct, other By mastering the difference, discovery teams can anticipate resistance, tune selectivity, and design Kenakin dissects how P450s can be both protective and problematic. Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.

  • Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift

    It is about building a team that can operate when clarity is missing. They determine whether skills can be applied at all.   Skills determine what someone can do when conditions are stable. They start asking whether that person can still be effective when the ground shifts under their feet. The goal is to build a team that can operate while uncertainty is present. 👉 Skills matter.

  • Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining

    By measuring the way these cells scatter light and emit fluorescence, they can be identified, quantified These limitations can impact data quality, reproducibility, and assay flexibility. Ideal for live cell low cytometry, which means you can monitor while preserving cellular integrity. 3 Innovations in the fluorophore tags, such as pH sensitive probes, can further improve signal-to-noise Autofluorescence and multiplexing: Using far-red or near-infrared fluorophores can reduce background

  • Why Opposing Processes Matter for Your Next GPCR Drug

    One wrong assumption about how your molecule behaves in a living system can sink months of work and millions Reflex arcs, compensatory pathways, and receptor trafficking can turn your expected outcome on its head In this session, you’ll gain: ✅ A mental model you can trust  for predicting how GPCR ligands behave You’ll understand why this is good news, not bad data, and how it can actually prevent harmful reflex Some can make a mediocre drug shine.

  • Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox

    Can we leverage structural and computational insights not just to explain receptor–ligand interactions computational chemistry, and drug discovery —rethinking how simulations, docking, and machine learning can Common questions in the group include: Can we forecast ligand efficacy or selectivity? Can we design compounds that trigger biased signaling? But part of their rigor lies in restraint. For drug discovery executives, the message is clear: predictive modeling can shorten timelines, reduce

  • From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations

    What makes you excel in the lab can quietly sabotage your leadership in the boardroom. 👉 Scientific those same instincts to analyze deeply, minimize error, and delay action until “enough” data is in can   ✅  This post explores how scientific thinking can become a leadership liability and what mindset In research, acting on incomplete or shaky data can destroy your credibility. But in the startup environment, these instincts can quickly become liabilities.

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    DMS can be used to comprehensively assess the functional impact of mutations in a candidate protein, helping to validate whether drugs can effectively target it. This high-resolution mapping can confirm the protein’s role in disease pathology and highlight allosteric By examining how mutations in the target protein affect its interaction with the drug, researchers can Mutations in target proteins can lead to decreased drug affinity and/or potency, rendering treatments

  • Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?

    (think batteries and balance scales), Terry reveals why different tissues—and even different assays—can From oxymetazoline to oxotremorine, discover how drugs can show up as full agonists in one system and

bottom of page